Secretory Leukocyte Proteinase Inhibitor-Competent DNA Deposits Are Potent Stimulators of Plasmacytoid Dendritic Cells: Implication for Psoriasis
Tóm tắt
Secretory leukocyte proteinase inhibitor (SLPI) is a well-established inhibitor of serine proteases such as human neutrophil elastase (HNE) and a NF-κB regulatory agent in immune cells. In this paper, we report that SLPI plays a previously uncharacterized role in regulating activation of plasmacytoid dendritic cells (pDCs). As the main source of IFN type I (IFNI), pDCs are crucial contributors to inflammatory and likely wound-healing responses associated with psoriasis. The mechanisms responsible for activation of pDCs in psoriatic skin are therefore of substantial interest. We demonstrate that in lesional skin of psoriasis patients, SLPI together with its enzymatic target HNE and DNA, is a component of neutrophil extracellular traps (NETs). Whereas SLPI+ neutrophils and NETs were found to colocalize with pDCs in psoriatic skin, a mixture of SLPI with neutrophil DNA and HNE induced a marked production of IFNI by pDCs. IFNI synthesis by stimulated pDCs was dependent on intracellular DNA receptor TLR9. Thus, SLPI may contribute to psoriasis by enabling pDCs to sense extracellular DNA and produce IFNI.
Từ khóa
Tài liệu tham khảo
Doumas, 2005, Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor., Infect. Immun., 73, 1271, 10.1128/IAI.73.3.1271-1274.2005
Jacobsen, 2008, The secretory leukocyte protease inhibitor (SLPI) and the secondary granule protein lactoferrin are synthesized in myelocytes, colocalize in subcellular fractions of neutrophils, and are coreleased by activated neutrophils., J. Leukoc. Biol., 83, 1155, 10.1189/jlb.0706442
Jin, 1997, Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide., Cell, 88, 417, 10.1016/S0092-8674(00)81880-2
Sallenave, 1997, Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils., J. Leukoc. Biol., 61, 695, 10.1002/jlb.61.6.695
Wingens, 1998, Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes., J. Invest. Dermatol., 111, 996, 10.1046/j.1523-1747.1998.00425.x
Reardon, 2011, Thymic stromal lymphopoetin-induced expression of the endogenous inhibitory enzyme SLPI mediates recovery from colonic inflammation., Immunity, 35, 223, 10.1016/j.immuni.2011.05.015
Zhu, 2002, Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair., Cell, 111, 867, 10.1016/S0092-8674(02)01141-8
Taggart, 2005, Secretory leucoprotease inhibitor binds to NF-κB binding sites in monocytes and inhibits p65 binding., J. Exp. Med., 202, 1659, 10.1084/jem.20050768
Xu, 2007, Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI., Nat. Immunol., 8, 294, 10.1038/ni1434
Subramaniyam, 2011, Secretory leukocyte protease inhibitor inhibits neutrophil apoptosis., Respirology, 16, 300, 10.1111/j.1440-1843.2010.01901.x
Remold-O’Donnell, 1989, Elastase inhibitor: characterization of the human elastase inhibitor molecule associated with monocytes, macrophages, and neutrophils., J. Exp. Med., 169, 1071, 10.1084/jem.169.3.1071
Faurschou, 2003, Neutrophil granules and secretory vesicles in inflammation., Microbes Infect., 5, 1317, 10.1016/j.micinf.2003.09.008
Fuchs, 2007, Novel cell death program leads to neutrophil extracellular traps., J. Cell Biol., 176, 231, 10.1083/jcb.200606027
Papayannopoulos, 2010, Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps., J. Cell Biol., 191, 677, 10.1083/jcb.201006052
Mantovani, 2011, Neutrophils in the activation and regulation of innate and adaptive immunity., Nat. Rev. Immunol., 11, 519, 10.1038/nri3024
Pinkus, 1966, The primary histologic lesion of seborrheic dermatitis and psoriasis., J. Invest. Dermatol., 46, 109, 10.1038/jid.1966.16
Garcia-Romo, 2011, Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus., Sci. Transl. Med., 3, 73ra20, 10.1126/scitranslmed.3001201
Hakkim, 2010, Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis., Proc. Natl. Acad. Sci. USA, 107, 9813, 10.1073/pnas.0909927107
Kessenbrock, 2009, Netting neutrophils in autoimmune small-vessel vasculitis., Nat. Med., 15, 623, 10.1038/nm.1959
Lande, 2011, Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus., Sci. Transl. Med., 3, 73ra19, 10.1126/scitranslmed.3001180
Lande, 2007, Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide., Nature, 449, 564, 10.1038/nature06116
Nestle, 2005, Plasmacytoid predendritic cells initiate psoriasis through interferon-α production., J. Exp. Med., 202, 135, 10.1084/jem.20050500
Liu, 2005, IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors., Annu. Rev. Immunol., 23, 275, 10.1146/annurev.immunol.23.021704.115633
Sørensen, 1997, The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils., Blood, 90, 2796, 10.1182/blood.V90.7.2796
Sørensen, 2001, Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3., Blood, 97, 3951, 10.1182/blood.V97.12.3951
Baugh, 1976, Human leukocyte granule elastase: rapid isolation and characterization., Biochemistry, 15, 836, 10.1021/bi00649a017
Chase, 1970, Titration of trypsin, plasmin and trombin with p-nitrophenyl-pʹ-guanidinobenzoate HCl., Methods Enzymol., 19, 20, 10.1016/0076-6879(70)19004-5
Travis, 1983, Human plasma proteinase inhibitors., Annu. Rev. Biochem., 52, 655, 10.1146/annurev.bi.52.070183.003255
Boudier, 1994, Oxidized mucus proteinase inhibitor: a fairly potent neutrophil elastase inhibitor., Biochem. J., 303, 61, 10.1042/bj3030061
Nobar, 2005, Oxidized elafin and trappin poorly inhibit the elastolytic activity of neutrophil elastase and proteinase 3., FEBS J., 272, 5883, 10.1111/j.1742-4658.2005.04988.x
Sambrook, 1982, Molecular Cloning: A Laboratory Manual.
Lin, 2011, Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis., J. Immunol., 187, 490, 10.4049/jimmunol.1100123
Morgan, 1991, Cloning of the cDNA for the serine protease homolog CAP37/azurocidin, a microbicidal and chemotactic protein from human granulocytes., J. Immunol., 147, 3210, 10.4049/jimmunol.147.9.3210
Cichy, 1997, Biosynthesis of α1-proteinase inhibitor by human lung-derived epithelial cells., J. Biol. Chem., 272, 8250, 10.1074/jbc.272.13.8250
Gregorio, 2010, Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons., J. Exp. Med., 207, 2921, 10.1084/jem.20101102
Fäh, 1995, Expression of MxA protein in inflammatory dermatoses., J. Histochem. Cytochem., 43, 47, 10.1177/43.1.7822763
van der Fits, 2004, In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-α sensitivity is unaltered., J. Invest. Dermatol., 122, 51, 10.1046/j.0022-202X.2003.22113.x
Downs, 2000, Exacerbation of psoriasis by interferon-α therapy for hepatitis C., Clin. Exp. Dermatol., 25, 351, 10.1046/j.1365-2230.2000.00655-4.x
Ketikoglou, 2005, Extensive psoriasis induced by pegylated interferon α-2b treatment for chronic hepatitis B., Eur. J. Dermatol., 15, 107